Side-by-side comparison of AI visibility scores, market position, and capabilities
NYC cloud-native observability platform at $1.6B valuation by Uber M3 founders; $340M+ General Atlantic/Greylock-backed Gartner Leader 2024 controlling observability costs for microservices competing with Datadog and Grafana.
Chronosphere is a New York-based cloud-native observability platform — backed by approximately $340 million in total funding including a $115 million Series C in 2023 at a $1.6 billion valuation, with investors including General Atlantic, Addition, Greylock, and Founders Fund — providing DevOps teams, site reliability engineers (SREs), and platform engineering organizations with a scalable metrics, logs, and traces observability platform built on the M3 open-source time-series database and OpenTelemetry standards, enabling engineering teams to monitor distributed microservices and cloud-native applications without the runaway observability cost growth that traditional platforms create as data volumes scale. Founded by Martin Mao and Rob Skillington, who built Uber's internal observability infrastructure (M3) before commercializing it as Chronosphere, the company was recognized as a Gartner Leader in the 2024 Observability Platform Magic Quadrant.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.